Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieke Maas

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Therapeutic Innovation & Regulatory Science|January 3, 2024
Pediatric Market Access: A Qualitative StudyLieke Maas, Angelika Joos, Mickael Hiligsmann
Expert Review of Pharmacoeconomics & Outcomes Research|June 11, 2024
Cost-effectiveness of a multicomponent-adherence intervention in fracture liaison servicesLieke Maas, Annelies Boonen, Nannan Li, et al.
Archives of Osteoporosis|May 13, 2024
Societal costs before and up to 1 year after the first fracture liaison service visit in patients requiring anti-osteoporosis treatmentsLieke Maas, Annelies Boonen, Caroline E Wyers, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 30, 2024
A quasi-experimental study about shared decision-making and motivational interviewing on patients with a recent fracture attending Fracture Liaison ServicesLieke Maas, Mickaël Hiligsmann, Caroline E Wyers, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 21, 2023
Development and usability of a decision aid to initiate anti-osteoporosis medication treatment in patients visiting the fracture liaison service with a recent fractureLieke Maas, Nele Raskin, Marloes van Onna, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Therapeutic Innovation & Regulatory Science|January 3, 2024
Pediatric Market Access: A Qualitative StudyLieke Maas, Angelika Joos, Mickael Hiligsmann
Expert Review of Pharmacoeconomics & Outcomes Research|June 11, 2024
Cost-effectiveness of a multicomponent-adherence intervention in fracture liaison servicesLieke Maas, Annelies Boonen, Nannan Li, et al.
Archives of Osteoporosis|May 13, 2024
Societal costs before and up to 1 year after the first fracture liaison service visit in patients requiring anti-osteoporosis treatmentsLieke Maas, Annelies Boonen, Caroline E Wyers, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 30, 2024
A quasi-experimental study about shared decision-making and motivational interviewing on patients with a recent fracture attending Fracture Liaison ServicesLieke Maas, Mickaël Hiligsmann, Caroline E Wyers, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 21, 2023
Development and usability of a decision aid to initiate anti-osteoporosis medication treatment in patients visiting the fracture liaison service with a recent fractureLieke Maas, Nele Raskin, Marloes van Onna, et al.
Pageof 1